Form 4: Cognition Therapeutics CEO Lisa Ricciardi Reports Tax-Related Stock Transaction
SEC Form 4 Filing
CEO Lisa Ricciardi reports disposition of shares to cover tax obligations related to vesting of restricted stock units.
Summary
- On February 15, 2025, Lisa Ricciardi, CEO & President and Director of Cognition Therapeutics Inc. [CGTX], engaged in a transaction involving common stock.
- Ricciardi disposed of 6,619 shares of common stock at a price of $0.5901 per share to cover tax withholding obligations related to the vesting of restricted stock units.
- Following the transaction, Ricciardi directly owns 887,066 shares of Cognition Therapeutics Inc.
Sentiment
Score: 5
Explanation: The document describes a routine transaction related to tax obligations, which is neutral in sentiment.
Industry Context
Form 4 filings are standard disclosures required by the SEC for corporate insiders, providing transparency into their transactions in the company's stock. This transaction is related to tax obligations, which is a common occurrence when restricted stock units vest.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is related to tax obligations and does not indicate a change in the CEO's overall confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 02/15/2025 | Date of stock transaction (disposal of shares for tax withholding). |
| 02/18/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.